Purespring Therapeutics
ID: 12839851Purespring Therapeutics is a gene therapy provider for kidney diseases founded in 2020.
2
Funding Rounds
$155.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Purespring Therapeutics has raised a total of $155m in funding over 2 rounds.
Key Insights:
- Purespring Therapeutics Series B Round, October 2024: $105m
- Purespring Series A round, July 30, 2021: $50m
Industries
Purespring Therapeutics is active in the following industries: